Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padraig Warde

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2008
A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancerJohn Waldron, Padraig Warde, Jon Irish, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomyKirsty L Wiltshire, Kristy K Brock, Masoom A Haider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized TrialMichael Brundage, Matthew R Sydes, Wendy R Parulekar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
The Journal of Urology|November 10, 2025
Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell TumoursAhmad Mousa, Julian Chavarriaga, Sanchit Kaushal, et al.
Lancet (London, England)|July 20, 2002
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialMichel Bolla, Laurence Collette, Léo Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Loss of p16 expression has prognostic significance in human nasopharyngeal carcinomaAntti A Mäkitie, Christina MacMillan, James Ho, et al.
European Urology Oncology|September 10, 2020
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell TumorGregory J Nason, Michael A S Jewett, Peter J Bostrom, et al.
Urology|February 1, 2020
Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the TestisGregory J Nason, Laura Donahoe, Marc de Perrot, et al.
The Lancet. Oncology|October 12, 2010
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyMichel Bolla, Geertjan Van Tienhoven, Padraig Warde, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2008
A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancerJohn Waldron, Padraig Warde, Jon Irish, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomyKirsty L Wiltshire, Kristy K Brock, Masoom A Haider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized TrialMichael Brundage, Matthew R Sydes, Wendy R Parulekar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
The Journal of Urology|November 10, 2025
Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell TumoursAhmad Mousa, Julian Chavarriaga, Sanchit Kaushal, et al.
Lancet (London, England)|July 20, 2002
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialMichel Bolla, Laurence Collette, Léo Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Loss of p16 expression has prognostic significance in human nasopharyngeal carcinomaAntti A Mäkitie, Christina MacMillan, James Ho, et al.
European Urology Oncology|September 10, 2020
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell TumorGregory J Nason, Michael A S Jewett, Peter J Bostrom, et al.
Urology|February 1, 2020
Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the TestisGregory J Nason, Laura Donahoe, Marc de Perrot, et al.
The Lancet. Oncology|October 12, 2010
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyMichel Bolla, Geertjan Van Tienhoven, Padraig Warde, et al.
Pageof 18